Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Aug 16;83(5):602–608. doi: 10.1054/bjoc.2000.1338

The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study

C Mitchell 1, P Morris Jones 2, A Kelsey 3, G M Vujanic 3, B Marsden 2, R Shannon 4, P Gornall 5, C Owens 6, R Taylor 7, J Imeson 8, H Middleton 8, J Pritchard 9
PMCID: PMC2363501  PMID: 10944599

Abstract

The aims of the UKW2 study were: (1) to further refine treatment for stage I and II favourable histology (FH) patients; (2) to consolidate the UKW1 results for stage III FH patients; (3) to improve the outlook for patients with inoperable primary tumours and those patients with stage IV and unfavourable histology disease. Treatment consisted of primary nephrectomy, wherever possible, followed by chemotherapy and radiotherapy, as dictated by stage and histology. Treatment was refined successfully for stage I and II FH patients. The 4-year event-free survival for these two groups was 94% and 91%, respectively. Stage III FH patients had a 4-year event free survival of 84%. The outlook for patients with clear cell sarcoma of the kidney is as good as for patients with favourable histology, whilst that for patients with anaplastic or rhabdoid variants remains poor. The outlook for the majority of children with Wilms’ tumour is now excellent. © 2000 Cancer Research Campaign

Keywords: Wilms’, tumour, treatment, chemotherapy, radiotherapy, childhood cancer

Full Text

The Full Text of this article is available as a PDF (72.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brennan P., Silman A. Statistical methods for assessing observer variability in clinical measures. BMJ. 1992 Jun 6;304(6840):1491–1494. doi: 10.1136/bmj.304.6840.1491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. D'Angio G. J., Breslow N., Beckwith J. B., Evans A., Baum H., deLorimier A., Fernbach D., Hrabovsky E., Jones B., Kelalis P. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer. 1989 Jul 15;64(2):349–360. doi: 10.1002/1097-0142(19890715)64:2<349::aid-cncr2820640202>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  3. D'Angio G. J., Evans A. E., Breslow N., Beckwith B., Bishop H., Feigl P., Goodwin W., Leape L. L., Sinks L. F., Sutow W. The treatment of Wilms' tumor: Results of the national Wilms' tumor study. Cancer. 1976 Aug;38(2):633–646. doi: 10.1002/1097-0142(197608)38:2<633::aid-cncr2820380203>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  4. D'Angio G. J., Evans A., Breslow N., Beckwith B., Bishop H., Farewell V., Goodwin W., Leape L., Palmer N., Sinks L. The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study. Cancer. 1981 May 1;47(9):2302–2311. doi: 10.1002/1097-0142(19810501)47:9<2302::aid-cncr2820470933>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  5. Godzinski J., Tournade M. F., De Kraker J., Ludwig R., Weirich A., Voute P. A., Burgers J. M., Habrand J. L., Sandstedt B., Ducourtieux M. The role of preoperative chemotherapy in the treatment of nephroblastoma: the SIOP experience. Societe Internationale d'Oncologie Pediatrique. Semin Urol Oncol. 1999 Feb;17(1):28–32. [PubMed] [Google Scholar]
  6. Green D. M., Breslow N. E., Beckwith J. B., Finklestein J. Z., Grundy P., Thomas P. R., Kim T., Shochat S., Haase G., Ritchey M. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol. 1998 Dec;16(12):3744–3751. doi: 10.1200/JCO.1998.16.12.3744. [DOI] [PubMed] [Google Scholar]
  7. Green D. M., Breslow N. E., Evans I., Moksness J., D'Angio G. J. Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group. Med Pediatr Oncol. 1996 Mar;26(3):147–152. doi: 10.1002/(SICI)1096-911X(199603)26:3<147::AID-MPO1>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  8. Green D. M., Breslow N. E., Evans I., Moksness J., Finklestein J. Z., Evans A. E., D'Angio G. J. Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group. J Natl Cancer Inst Monogr. 1995;(19):21–25. [PubMed] [Google Scholar]
  9. Green D. M., Coppes M. J. Future directions in clinical research in Wilms tumor. Hematol Oncol Clin North Am. 1995 Dec;9(6):1329–1339. [PubMed] [Google Scholar]
  10. Green D. M., D'Angio G. J., Beckwith J. B., Breslow N. E., Grundy P. E., Ritchey M. L., Thomas P. R. Wilms tumor. CA Cancer J Clin. 1996 Jan-Feb;46(1):46–63. doi: 10.3322/canjclin.46.1.46. [DOI] [PubMed] [Google Scholar]
  11. Green D. M., Finklestein J. Z., Norkool P., D'Angio G. J. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine. A report of the National Wilms' Tumor Study. Cancer. 1988 Jul 15;62(2):270–273. doi: 10.1002/1097-0142(19880715)62:2<270::aid-cncr2820620208>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  12. Kumar R., Fitzgerald R., Breatnach F. Conservative surgical management of bilateral Wilms tumor: results of the United Kingdom Children's Cancer Study Group. J Urol. 1998 Oct;160(4):1450–1453. doi: 10.1016/s0022-5347(01)62588-6. [DOI] [PubMed] [Google Scholar]
  13. Lennox E. L., Stiller C. A., Jones P. H., Wilson L. M. Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. Br Med J. 1979 Sep 8;2(6190):567–569. doi: 10.1136/bmj.2.6190.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lipshultz S. E., Colan S. D., Gelber R. D., Perez-Atayde A. R., Sallan S. E., Sanders S. P. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991 Mar 21;324(12):808–815. doi: 10.1056/NEJM199103213241205. [DOI] [PubMed] [Google Scholar]
  15. Pachnis A., Pritchard J., Gaze M., Levitt G., Michalski A. Radiotherapy omitted in the treatment of selected children under 3 years of age with stage III favorable histology Wilms tumor. Med Pediatr Oncol. 1998 Sep;31(3):150–152. doi: 10.1002/(sici)1096-911x(199809)31:3<150::aid-mpo4>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  16. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pritchard J., Imeson J., Barnes J., Cotterill S., Gough D., Marsden H. B., Morris-Jones P., Pearson D. Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study. J Clin Oncol. 1995 Jan;13(1):124–133. doi: 10.1200/JCO.1995.13.1.124. [DOI] [PubMed] [Google Scholar]
  18. Raine J., Bowman A., Wallendszus K., Pritchard J. Hepatopathy-thrombocytopenia syndrome--a complication of dactinomycin therapy for Wilms' tumor: a report from the United Kingdom Childrens Cancer Study Group. J Clin Oncol. 1991 Feb;9(2):268–273. doi: 10.1200/JCO.1991.9.2.268. [DOI] [PubMed] [Google Scholar]
  19. Sorensen K., Levitt G., Sebag-Montefiore D., Bull C., Sullivan I. Cardiac function in Wilms' tumor survivors. J Clin Oncol. 1995 Jul;13(7):1546–1556. doi: 10.1200/JCO.1995.13.7.1546. [DOI] [PubMed] [Google Scholar]
  20. Tournade M. F., Com-Nougué C., Voûte P. A., Lemerle J., de Kraker J., Delemarre J. F., Burgers M., Habrand J. L., Moorman C. G., Bürger D. Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor. J Clin Oncol. 1993 Jun;11(6):1014–1023. doi: 10.1200/JCO.1993.11.6.1014. [DOI] [PubMed] [Google Scholar]
  21. de Kraker J., Lemerle J., Voûte P. A., Zucker J. M., Tournade M. F., Carli M. Wilm's tumor with pulmonary metastases at diagnosis: the significance of primary chemotherapy. International Society of Pediatric Oncology Nephroblastoma Trial and Study Committee. J Clin Oncol. 1990 Jul;8(7):1187–1190. doi: 10.1200/JCO.1990.8.7.1187. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES